Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
111.90
3.7 (3.42%)
BSENSE

Mar 05

BSE+NSE Vol: 3.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.0 lacs (22.01%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 4 FIIs

DII

4.40%

Held by 1 DIIs

Promoter

52.68%

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

The next results date for Anlon Healthcare Ltd is scheduled for 09 February 2026.

View full answer

Why is Anlon Healthcare Ltd falling/rising?

05-Mar-2026

As of 04-Mar, Anlon Healthcare Ltd's stock price is currently at 109.25, reflecting a decline of 2.15% and a significant underperformance compared to its sector. The stock has shown a bearish trend, trading below all key moving averages and experiencing a year-to-date decrease of 27.82%.

As of 04-Mar, Anlon Healthcare Ltd's stock price is falling, currently at 109.25, reflecting a decrease of 2.4 points or 2.15%. The stock has underperformed its sector by 1.06% today and has experienced a trend reversal, having fallen after two consecutive days of gains. The stock reached an intraday low of Rs 107.4, which is a decline of 3.81%. Additionally, Anlon Healthcare is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 72.61% against the 5-day average, the overall performance over the past month shows a significant decline of 15.18%, compared to a lesser drop of 5.61% in the benchmark Sensex. Year-to-date, the stock has decreased by 27.82%, while the Sensex has only fallen by 7.16%. These factors contribute to the current downward movement in Anlon Healthcare Ltd's stock price.

View full answer

Which are the latest news on Anlon Healthcare?

05-Mar-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 577 Cr (Micro Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

9.57%

stock-summary
Price to Book

2.71

Revenue and Profits:
Net Sales:
36 Cr
(Quarterly Results - Dec 2025)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-24.85%
0%
-24.85%
6 Months
21.7%
0%
21.7%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Closure of Trading Window

02-Mar-2026 | Source : BSE

We have attached notice of closure of Trading Window for dealing in securities of the Company as per SEBI (PIT) Regulation Kindly take the same on your record. Thank you.

Board Meeting Intimation for Stock Split And Issue Of Bonus Shares

02-Mar-2026 | Source : BSE

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2026 inter alia to consider and approve 1. To consider and approve subject to shareholders approval the subdivision (stock split) of existing equity shares of the Company and to fix the Record Date for the same if approved. 2. To consider and recommend to increase in Authorized Share Capital and consequential Alteration in Capital Clause of the Memorandum of Association of the Company. 3. To consider and approve subject to shareholders approval the issue of Bonus Equity Shares to the equity shareholders of the Company on such terms and in such proportion as may be determined by the Board of Directors. 4. Any other business(s) with permission of the Chair if any. You are requested to take the above information on your record. Thanking You.

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

27-Feb-2026 | Source : BSE

We have attached herewith announcement regarding amendment in Share Purchase Agreement executed between Anlon Healthcare Limited and Bizotic Lifescience Private Limited. Kindly take the same on your record. Thank you.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
8.18
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
23.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.72%
ROCE (avg)
9.07%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
29
Industry P/E
32
Price to Book Value
2.78
EV to EBIT
20.02
EV to EBITDA
18.92
EV to Capital Employed
2.66
EV to Sales
5.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.30%
ROE (Latest)
9.57%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Mildly Bearish
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (0.23%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

23.58%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.58",
          "val2": "52.20",
          "chgp": "-31.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.34",
          "val2": "13.73",
          "chgp": "-10.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.58",
          "val2": "0.87",
          "chgp": "81.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.15",
          "val2": "9.32",
          "chgp": "-44.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.68%",
          "val2": "26.30%",
          "chgp": "8.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.32",
          "val2": "15.03",
          "chgp": "115.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.26",
          "val2": "2.80",
          "chgp": "16.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.69%",
          "val2": "21.06%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
35.58
52.20
-31.84%
Operating Profit (PBDIT) excl Other Income
12.34
13.73
-10.12%
Interest
1.58
0.87
81.61%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.15
9.32
-44.74%
Operating Profit Margin (Excl OI)
34.68%
26.30%
8.38%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
85.50
62.00
37.90%
Operating Profit (PBDIT) excl Other Income
19.98
14.45
38.27%
Interest
1.68
1.91
-12.04%
Exceptional Items
0.00
0.00
Standalone Net Profit
12.86
6.36
102.20%
Operating Profit Margin (Excl OI)
23.37%
23.31%
0.06%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
121.08
71.36
69.67%
Operating Profit (PBDIT) excl Other Income
32.32
15.03
115.04%
Interest
3.26
2.80
16.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.01
3.87
365.37%
Operating Profit Margin (Excl OI)
26.69%
21.06%
5.63%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
120.29
NA
NA
Operating Profit (PBDIT) excl Other Income
32.21
NA
NA
Interest
3.72
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
20.52
NA
NA
Operating Profit Margin (Excl OI)
26.78%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Anlon Healthcare Ltd stock-summary
stock-summary
Anlon Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available